J43.1
Panlobular emphysema
Clinical Classification Guidelines
Inclusion Terms
- Panacinar emphysema
Medical Intelligence & Overview
Panlobular emphysema, also known as panacinar emphysema, is a type of chronic obstructive pulmonary disease (COPD) that primarily affects the air sacs (alveoli) in the lungs. This condition leads to abnormal expansion and destruction of alveoli, resulting in decreased oxygen exchange and breathing difficulties. It's most commonly associated with alpha-1 antitrypsin deficiency but can also occur due to other environmental and genetic factors.
Causes & Symptoms
Clinical Causes: Genetic mutations, particularly alpha-1 antitrypsin deficiency Long-term exposure to cigarette smoke Environmental pollutants and air pollution Inhalation of harmful fumes or dust Repeated lung infections that damage lung tissue Aging-related lung changes
Key Symptoms: Shortness of breath, especially during physical activity Persistent cough with mucus production Wheezing or a whistling sound during breathing Chest tightness or discomfort Fatigue and tiredness Unintentional weight loss in advanced cases Frequent respiratory infections
Diagnostic & Treatment
Diagnosis Path: Diagnosing panlobular emphysema involves a combination of clinical evaluation and diagnostic tests. Healthcare providers may perform:
Treatment Protocols: While there is no cure for panlobular emphysema, various treatments can help manage symptoms and improve quality of life. These include:
Clinical Advice & FAQs
Billing Guidance
Is J43.1 a billable ICD-10 code?
Yes, J43.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report J43.1?
Clinical documentation must specify the nature of Panlobular emphysema and any associated comorbidities for accurate reporting.
Cite this Clinical Reference